Overview

Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus

Status:
Completed
Trial end date:
2019-03-10
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study was to evaluate the effect of oral lycopene and systemic steroids in the treatment of erosive oral lichen planus and compare between the two therapeutic modalities.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nourhan M.Aly
Collaborator:
Alexandria University
Treatments:
Lycopene
Prednisolone
Criteria
Inclusion Criteria:

- Erosive oral lichen planus patients with severe and extensive painful erythematous,
erosive and/ or ulcerative lesions who are in need for systemic corticosteroid therapy

Exclusion Criteria:

- Pregnant females and smokers.

- Patients suggestive of having lichenoid contact/drug reactions.

- Patients suffering from any systemic disease as diabetes, liver disease, renal
disease, any other autoimmune or collagen disease.

- Lesions showing histological features of dysplasia.

- Patients with skin lichen planus lesions.